SalioGen Therapeutics

Last updated: January 17, 2024

CEO Ray Tabibiazar
CEO Ray Tabibiazar
Country: USA | Funding: $135M (+)

Website: https://saliogen.com/

SalioGen advances in genetic therapies using its Exact DNA Integration Technology platform, a mammal-derived genome engineering technology.